Morgan Stanley
-
-
-
-
-
-
-
AbbVie (ABBV) to Acquire Cerevel Therapeutics (CERE) for $45 Per Share, $8.7 Billion Deal
-
-
-
-
-
-
-
Morgan Stanley Issues Catalyst Driven Idea on Abbvie (ABBV)
-
-
-
-
-
-
-
AbbVie to Present at the Morgan Stanley Healthcare Conference
-
-
-
-
-
-
-
AbbVie (ABBV) In Talks To Sell $5 Billion Women's Drugs Portfolio In Morgan Stanley-led Auction - Reuters
-
-
-
-
-
-
-
Pre-Open Stock Movers 04/27: (AXSM) (HARP) (AUDC) Higher; (DO) (VSTM) (CAT) Lower (more...)
-
-
-
-
-
-
-
Abbvie (ABBV) PT Lowered to $88 at Morgan Stanley
-
-
-
-
-
-
-
Abbvie (ABBV) PT Raised to $131 at Morgan Stanley
-
211,042 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

